Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 86, Issue 1-2, 2012, Pages 51-59

  Krul, E S ^a   Lemke, S L ^b   Mukherjea, R ^a   Taylor, M L ^b   Goldstein, D A ^b   Su, H ^b   Liu, P ^a   Lawless, A ^d   Harris, W S ^c   Maki, K C ^d  

^a Solae LLC   (United States)

^b MONSANTO COMPANY   (United States)

^c SANFORD RESEARCH   (United States)

^d Provident Clinical Research/Biofortis North America   (United States)

Author keywords

Dosage response; Eicosapentaenoic acid; Omega 3 fatty acids; RBC; Stearidonic acid

Indexed keywords

ICOSAPENTAENOIC ACID; PLACEBO; SAFFLOWER OIL; SOYMEGA; STEARIDONIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DYSPEPSIA; EICOSAPENTAENOIC ACID CELL LEVEL; ERYTHROCYTE MEMBRANE; FAT INTAKE; FEMALE; FLATULENCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; NAUSEA; NORMAL HUMAN; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH DISCOMFORT; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CAPSULES; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; SINGLE-BLIND METHOD; TIME FACTORS;

CARTHAMUS TINCTORIUS;

EID: 84155162472     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.10.005     Document Type: Article

References (39)

1. Kris-Etherton P.M., Harris W.S., L.J.Appel for the Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
2. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., Franklin B., Kris-Etherton P., Harris W.S., Howard B., Karanja N., Lefevre M., Rudel L., Sacks F., Van Horn L., Winston M., Wylie-Rosett J. Diet and lifestyle recommendations; Revision 2006: A Sci. Statement Am. Heart Assoc. Nutr. Comm. Circ. 2006, 114:82-96.
3. EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA) Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010, 8:1461.
4. Harper C.R., Jacobson T.A. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am. J. Cardiol. 2005, 96:1521-1529.
5. Stone N.J. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 1996, 94:2337-2340.
6. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
7. Albert C.M., Hennekens C.H., O'Donnell C.J., Ajani U.A., Carey V.J., Willett W.C., Ruskin J.N., Manson J.E. Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23-28.
8. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., Tracy R.P., Siscovick D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The cardiovascular health study. Am. J. Clin. Nutr. 2003, 77:319-325.
9. Saito Y., Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., Shirato K., JELIS Investigators Japan, effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008, 200:135-140. Erratum in: Atherosclerosis 204 (2009) 233.
10. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., Shirato K., Japan EPA lipid intervention study (JELIS) Investigators effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098. Erratum in: Lancet 370 (2007) 220.
11. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., Bovbjerg V., Arbogast P., Smith H., Kushi L.H., Cobb L.A., Copass M.K., Psaty B.M., Lemaitre R., Retzlaff B., Childs M., Knopp R.H. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
12. Harris W.S., Sands S.A., Windsor S.L., Ali H.A., Stevens T.L., Magalski A., Porter C.B., Borkon A.M. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: Correlation with erythrocytes and response to supplementation. Circulation 2004, 21:1645-1649.
13. Harris W.S., Von Schacky C. The omega-3 index: A new risk factor for death from coronary heart disease?. Prev. Med. 2004, 39:212-320.
14. Harris W.S. The omega-3 index: From biomarker to risk marker to risk factor. Curr. Atheroscler Rep. 2009, 11:411-417.
15. Mahaffey K.R., Clickner R.P., Jeffries R.A. Methylmercury and omega-3 fatty acids: Co-occurrence of dietary sources with emphasis on fish and shellfish. Environ. Res. 2008, 107:20-29.
16. Ursin V.M. Modification of plant lipids for human health: Development of functional land-based omega-3 fatty acids. J. Nutr. 2003, 133:4271-4274.
17. Jenkins D.J., Sievenpiper J.L., Pauly D., Sumaila U.R., Kendall C.W., Mowat F.M. Are dietary recommendations for the use of fish oils sustainable?. CMAJ 2009, 180:633-637.
18. Simpson S. The blue food revolution. Sci. Am. 2011, 304:54-61.
19. Arterburn L.M., Bailey E., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83:1467S-1476S.
20. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 2005, 45:581-597.
21. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 2001, 42:1257-1265.
22. James M.J., Ursin V.M., Cleland L.G. Metabolism of stearidonic acid in human subjects: Comparison with the metabolism of other n-3 fatty acids. Am. J. Clin. Nutr. 2003, 77:1140-1145.
23. Harris W.S., Lemke S.L., Hansen S.N., Goldstein D.A., DiRienzo M.A., Su H., Nemeth M.A., Taylor M.L., Ahmed G., George C. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43:805-811.
24. Lemke S.L., Vicini J.L., Su H., Goldstein D.A., Nemeth M.A., Krul E.S., Harris W.S. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: Randomized, double-blind clinical study of efficacy and safety. Am. J. Clin. Nutr. 2010, 92:766-775.
25. Diboune M., Ferard G., Ingenbleek Y., Tulasne P.A., Calon B., Hasselmann M., Sauder P., Spielman D., Metais P. Composition of phospholipid fatty acids in red blood cell membranes of patients in intensive care units: Effects of different intakes of soybean oil, medium-chain triglycerides, and black-currant seed oil. J. Parenter. Enteral Nutr. 1992, 16:136-141.
26. Dayton S., Hashimoto S., Dixon W., Pearce M.L. Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J. Lipid Res. 1966, 7:103-111.
27. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study. J. Lipid Res. 1997, 38:2012-2022.
28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
29. Umstead T.M., Lu C.-J.K., Freeman W.M., Myers J.L., Clark B., Thomas N.J., Chinchilli V.M., Vrana K.E., Undar A., Phelps D.S. Dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr. Res. 2010, 67:641-649.
30. Yu X., Schniederhan-Marra N., Joos T.O. Protein microarrays for personalized medicine. Clin. Chem. 2010, 56:376-387.
31. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
32. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C., International Society for the Study of Fatty Acids and Lipids ISSFAL, alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80:85-91.
33. U.S.Department of Agriculture and U.S.Department of Health and Human Services Dietary Guidelines for Americans 2010, U.S. Government Printing Office, Washington, DC, December 2010. 7th Edition.
34. Whittinghill J., Welsby D. Use of SDA soybean oil in bakery applications. Lipid Technol. 2010, 22:203-205.
35. Phelan N., O'Connor A., Tun T.K., Cooreia N., Boran G., Roche H.M., Gibney J. Hormonal and metabolic effects of polyunsaturated fatty acids in women with polycystic ovary syndrome: Results from a cross-sectional analysis and randomized, placebo-controlled crossover trial. Am. J. Clin. Nutr. 2011, 93:652-662.
36. Spite M., Serhan C.N. Novel lipid mediators promote resolution of acute inflammation: Impact of aspirin and statins. Circ. Res. 2010, 107:1170-1184.
37. Liou Y.A., King D.J., Zibrik D., Innis S.M. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J. Nutr. 2007, 137:945-952.
38. Neubronner J., Schuchardt J.P., Kressel G., Merkel M., von Schacky C., Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur. J. Clin. Nutr. 2011, 65:247-254.
39. Dyerberg J., Madsen P., Møller J.M., Aardestrup I., Schmidt E.B. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot. Essent. Fatty Acids 2010, 83:137-141.